Thibaut Vaysse

Statistics

Publications

Citations

1.8K

H-Index

Active since

2016

Affiliations

Bicêtre Hospital(Current)

Assistance Publique – Hôpitaux de Paris

Sorbonne Université

Hôpital Saint-Antoine

Inserm

Thibaut Vaysse is an author at Bicêtre Hospital specializing in gastrointestinal inflammation, ulcerative colitis pharmacotherapy, and inflammatory bowel disease therapy.

Publications per year

2016–2019

Publications

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Nathalie Chaput, Patricia Lepage, Clélia Coutzac et al. · Annals of Oncology · 2017 · 1.3K citations

Life Sciences, Immunology, Oncology +16

One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Aurélien Amiot, Mélanie Serrero, Laurent Peyrin‐Biroulet et al. · Alimentary Pharmacology & Therapeutics · 2017 · 177 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the <scp>OBSERV</scp>‐<scp>IBD</scp> cohort

S. Tadbiri, Laurent Peyrin‐Biroulet, Mélanie Serrero et al. · Alimentary Pharmacology & Therapeutics · 2017 · 112 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Loriane Lair-Mehiri, Carmen Stefănescu, Thibaut Vaysse et al. · Digestive and Liver Disease · 2019 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors

Alice de Malet, Guillemette Antoni, Michael Collins et al. · European Journal of Cancer · 2018 · 56 citations

Life Sciences, Immunology, Oncology +14

1–5 of 8